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A B S T R A C T
Background: Prevention of osteoporosis and bone fracture and the relationship between metabolic
syndrome and bone density are controversial issues.
The aim of this study: The aim of this study was to evaluate the association between metabolic syndrome
and its components with bone mineral density in post menopausal women referred for bone mineral
density (BMD) test.
Methods: A total of 143 postmenopausal women with at least one year of menopause experience
participated in this cross-sectional study. Demographic and anthropometric characteristics for all
participants were collected. Also, biochemical parameters including fasting blood sugar, Cholesterol
(HDL and LDL), triglyceride were measured. Association between the components of metabolic syndrome
and bone densitometry were analyzed by statistical methods.
Results: In this study, 72% of participants did not have metabolic syndrome. Among them, 43.4% and 28.7%
had osteoporosis and normal density, respectively. Of remaining participants with metabolic syndrome,
12.6% and 15.4% had osteoporosis and normal density, respectively. Among the metabolic syndrome
components, waist circumference, HDL cholesterol, and waist to hip ratio were signiﬁcantly associated
with bone mass (P < 0.05). Osteoporotic women had lower waist circumference and waist to hip ratio and
higher HDL than women without osteoporosis. On the other hand, women with metabolic syndrome did
not have signiﬁcant differences than women without metabolic syndrome in terms of lumbar and
femoral neck density (P > 0.05).
Conclusion: Results from this study showed that metabolic syndrome and its components did not induce
bone mass loss. The discrepancies of the studies in this area call for more large scale studies in population
so as to prevent women problems in this area.
© 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.
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Metabolic syndrome refers to a set of conditions that occur
together including high blood pressure, elevated insulin level in
blood, increased body fat around the waist, high triglyceride, and
low HDL cholesterol. Simultaneous existence of these conditions
increases the risk of heart disease, stroke, and diabetic status [1,2].
The literature review shows that increasing CRP (a marker of
systemic inﬂammation) is associated with osteoporosis and non-
traumatic fractures [3]. Also, the metabolic syndrome is a disease
that is associated with the presence of inﬂammation in the body
[4]. Therefore, systemic inﬂammation associated with metabolic* Correspondence to: Qazvin University of Medical Sciences, Qazvin, Iran.
E-mail address: yazdizohreh@yahoo.com (Z. Yazdi).
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1871-4021/© 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.syndrome may activate bone resorption process that leads to
reduced bone density [5]. On the other hand, other component of
the metabolic syndrome (obesity or increased body mass index) is
known as a protective factor against the development of
osteoporosis [6]. Therefore, in patients with metabolic syndrome,
simultaneous action of two factors with opposite effects on bone
mineral density has been observed. These factors include obesity
as a known protective factor against osteoporosis and inﬂamma-
tory processes that activate bone resorption [1,5]. Previous studies
have investigated the association between these factors and
osteoporosis, but the results of these studies are inconsistent [7].
For example, the results regarding the relationship between high
triglyceride and low levels of HDL cholesterol with bone mineral
density (BMD) is incompatible. Moreover, there are conﬂicting
reports about the relationship between high blood pressure and
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protects the individual against bone loss while aging, studies have
shown that abdominal obesity is associated with osteopenia and
osteoporosis [10]. Some studies have mentioned hyperglycemia as
a predictor of low bone mass or osteoporosis, but have not reached
a deﬁnitive conclusion about its relationship with BMD [10,11].
Although the inﬂammation caused by metabolic syndrome can
lead to a decrease in bone density, recent studies have reported
that metabolic syndrome reduces the risk of non-costal bone
fractures [8,12].
Due to the above mentioned reasons and the importance of
prevention of osteoporosis and bone fractures, the relationship
between metabolic syndrome and bone density is still a
controversial issue. The aim of this study was to evaluate the
association between metabolic syndrome and its components with
bone density in women referred for bone mineral density (BMD)
test.
2. Methods
This cross-sectional study was done in rheumatology depart-
ment of a university hospital in Qazvin. One hundred forty three
women aged between 39 to 87 years were enrolled from patients
referred for bone densitometry. In this study, sampling was done
through non-probability sampling method. This study was
conducted in accordance with the research priorities of Qazvin
University of Medical Sciences and was approved by the ethics
committee of the university. Informed consent was taken from all
patients. Inclusion criteria included all women who were referred
for bone densitometry. Exclusion criteria were a history of
rheumatic diseases such as rheumatoid arthritis in patients and
use of corticosteroids. Structured medical interviews and medical
examinations by rheumatologist were done for all patients.
Women with diagnosis of osteoporosis in BMD test were
considered as patients while those with normal result of BMD
were considered as healthy women. The Bone Mineral Density was
measured using dual-energy X-ray absorptiometry at lumbar spine
and femoral neck (Hologic QDR 2000, Bedford, MA, USA model)
[13]. Results of BMD were categorized according to the WHO
criteria. According the WHO criteria, women with spine or femur
neck T-score equal or below 2.5 were considered as having
osteoporosis. T-score between 1 to 2.5 and more than 1 were
considered as having osteopenia and normal people, respectively.
Other patients’ information including age (year), height
(meter), weight (kilogram), and years from menopause were
recorded. Body mass index (BMI) was calculated by dividing
weight (in kilograms) by the square of weight. Waist and hip
circumferences were measured at the level of the umbilicus and
the symphysis of pubis, respectively. Also, the ratio between these
two indices was calculated. Blood biochemical tests including
fasting blood sugar, high density lipoprotein cholesterol, and lowTable 1
comparison results from anthropometric data and biochemical blood tests between pa
Normal bone density (n = 6
Waist circumference (cm) 101.58  9.15 
Waist to hip ratio 0.92  0.9 
Systolic blood pressure (mmhg) 121.74  19.55 
Diastolic blood pressure (mmhg) 74.12  13.29 
Fasting blood sugar (mg/dl) 112.11  49.55 
HDL (mg/dl) 50.33  11.76 
LDL (mg/dl) 113.41  32.76 
TG (mg/dl) 153.5  72.02 
Age (years) 53.47  7.33 
BMI (kg/m2) 31.61  7.95 
* p < .05 instudent t-test used for comparison between groups.density lipoprotein cholesterol were done for all the participants.
Women with and without a diagnosis of metabolic syndrome were
considered as positive and negative exposure, respectively.
The diagnosis of metabolic syndrome was done using the
criteria proposed by the Third Report of the National Cholesterol
Education Program [14]. According to the criteria, diagnosis of
metabolic syndrome requires three or more of the followings:
waist circumference 88 cm; high blood pressure (systolic blood
pressure 130 mmhg and diastolic blood pressure 85 mmhg);
HDL cholesterol 50 mg/dl; and fasting blood sugar 100 mg/dl.
Distribution of all anthropometric and laboratory data were
evaluated. Data were presented using frequency and percentage
for categorical variables. Chi-square test was used to compare
qualitative variables, and independent t-test was used for compare
continuous variables. All statistical analyses were performed using
SPSS software version 19 and p-value less than 0.05 was
considered statistically signiﬁcant.
3. Results
A total of 143 women participated in this study. Among them,
80 (55.9%) patients suffered from osteoporosis, and 40 (28%)
patients had metabolic syndrome. Table 1 compares results from
anthropometric data and biochemical blood tests between
patients with normal bone density and osteoporosis. As seen in
Table 1, variables including age, waist circumference and waist-hip
ratio was signiﬁcantly different in those with normal bone density
than osteoporotic patients (P-value < 0.05).
The mean age of the patients with normal bone density was 33/
7 47/53, compared to 21/8  03/60 in osteoporotic patients. This
difference was statistically signiﬁcant (P = 0.001). Also, mean waist
circumference in normal bone density and osteoporotic group was
101.6  9.1 and 95.9  11.9, respectively. Its difference was statisti-
cally signiﬁcant (P = 0.002) as well. In relation to blood biochemical
parameters, only HDL cholesterol was signiﬁcantly higher in
osteoporotic women than those with normal density (P = 0.031).
Analysis of variables in this study was also performed using
criteria proposed by NCEP (ATPIII). As seen in Table 2, twenty two
women had a waist circumference less than 88 centimeters, among
which, 19 (13.3%) patients suffered from osteoporosis and 3 (2.1%)
patients had normal bone density. On the other hand, one hundred
twenty one women had a waist circumference higher than 88
centimeters, among which, 61 (42.7%) patients suffered from
osteoporosis and 60 (42%) patients had normal bone density. This
difference were analyzed using chi-square test and was meaning-
ful (P = 0.002). Another signiﬁcant variable in the results was HDL
cholesterol. Twenty four women of the total participants had HDL
cholesterol level of 50, among which, 13 (9.09%) and 11 (7.69%)
were osteoporotic and normal women, respectively (P = 0.031).
Results for other biochemical parameters (fasting blood sugar and
triglyceride) and blood pressure are shown in Table 2. Overall, as ittients with normal bone density and osteoporosis.
3) Osteoporosis (n = 80) P-value
95.92  11.97 0.002*
0.88  0.86 0.002*
119.45  18.29 0.471
70.5  14.31 0.124
102.91  30.71 0.175
55.03  13.55 0.031*
116.3  35.28 0.617
133.8  65.96 0.091
60.03  8.21 0.001*
33.64  9.22 0.75
Table 2
comparison between patients with normal bone density and osteoporosis in terms
of NCEP parameters.
Normal bone
density
Osteoporosis p-value
Waist circumference (cm) 0.002*
<88 3 (2.1%) 19 (13.29%)
> = 88 60 (41.96%) 61 (42.66%)
Fasting blood sugar (mg/dl) 0.144
<100 35 (24.48%) 54 (37.76%)
> = 100 28 (19.58%) 26 (18.18%)
HDL (mg/dl) 0.031*
> = 50 52 (36.36%) 67 (46.85%)
<50 11 (7.69%) 13 (9.09%)
TG (mg/dl) 0.079
<150 36 (25.17%) 57 (39.86%)
> = 150 27 (18.88%) 23 (16.08%)
Blood pressure (mmhg) 0.542
<130/85 52 (36.36%) 69 (48.25%)
> 150 11 (7.69%) 11 (7.69%)
Metabolic syndrome 0.1
Yes 41 (28.67%) 62 (43.36%)
No 22 (15.38%) 18 (12.59%)
* p < .05 inchi-square test used for comparison between groups.
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have metabolic syndrome including 62 osteoporotic women and
41 subjects with normal bone density. It should be noted that
according to the results of the chi-square test, no signiﬁcant
difference was observe between the groups with and without
metabolic syndrome in terms of developing osteoporosis (P = 0.1).
Table 3 compares bone mineral density in two part of body
(lumbar spine and neck of femur) based on presence or absence of
metabolic syndrome in the participants. All bone density results
are presented based on g/cm2. Women with metabolic syndrome
had slightly higher T-score and BMD than women without it, but
this difference was not statistically signiﬁcant (P-value > 0.05).
4. Discussion
Since there was a few information about the prevalence of
metabolic syndrome in osteoporotic women in Qazvin province,
this study evaluated the prevalence and most common features of
metabolic syndrome in osteoporotic women referred to bone
densitometry center. The ﬁndings were similar to other studies
which have shown that metabolic syndrome cause a slight increase
in bone density [13]. Other results showed that the prevalence of
osteoporosis in women with metabolic syndrome was lower than
those without it. However, this difference was statistically
signiﬁcant in some parameters. In a study conducted by Kinjo
et al. similar results were found [15].
The most important parameters of metabolic syndrome which
were associated with bone densitometry included the mean of
waist circumference, mean HDL cholesterol, and waist to hip ratio.Table 3
results of bone densitometry according suffering from metabolic syndrome.
Bone densitometry parameters Without MS (n = 103) 
BMD spine (g/cm2) L1-L4 0.96  0.15 
T-score in lumbar spine 1.12  1.3 
BMD femoral neck (g/cm2) 0.79  0.12 
T-score in femoral neck 1.11  1.1 
student t-test used for comparison between groups.Also, the mean age of patients with normal bone density was lower
than those with osteoporosis. The results of previous study have
shown that prevalence of metabolic syndrome and osteoporosis in
women increases with age. Finally, these diseases lead to poor
quality of life and increased morbidity and mortality in older age
[7].
In this study, mean serum HDL in women with normal bone
mineral density was signiﬁcantly lower than in women with
osteoporosis. While in another study conducted in 2010 in Korea,
serum HDL level were positively associated with BMD and
protected women against osteoporosis [16]. Kim and colleagues
also found similar results that are inconsistent with the results of
present study [17]. As mentioned earlier, existing reports on the
level of HDL and BMD are conﬂicting and therefore these
differences need further investigations [8,9].
In our study, the mean of waist circumference and waist to hip
ratio in women with normal bone mineral density was signiﬁcantly
higher than women with osteoporosis. These results are consistent
with a study conducted by Alissa and colleagues [8], and is contrary
to Kim’s study [17]. Thus it can be stated that in this study waist
circumference (among other parameters of metabolic syndrome)
were signiﬁcantly associated with bone densitometry.
The literature review shows that obesity act as a protective
factor against bone loss in older people. Accumulation of
abdominal fat is also one of the main features of the metabolic
syndrome that is often associated with obesity [18].
Similar to another study that was conducted in this area, it was
expected that lower values of fasting blood sugar are seen in
subjects with normal bone density than those with osteoporosis
[17,19]. Such relationship; however, was not achieved in present
study.
In this study, signiﬁcant association was not observed between
BMD results with systolic and diastolic blood pressure that was
consistent with other study conducted by Mussolino et al. [20]
while other studies have reported the existence of this relation-
ship, especially in diastolic blood pressure. The exact reason for
this relationship is not clear, yet changes in serum concentration of
PTH or urine calcium exertion has been described as the main
cause [20,21].
In this study, the mean level of triglyceride was greater than the
osteoporotic individuals. But, the difference was not statistically
signiﬁcant. It seems that triglyceride level is associated with BMD
especially at the hip region [16]. This is not common in all studies,
because only some studies have shown that triglyceride level is
effective in reducing the risk of fracture [19].
The BMI (body mass index) is known as one of the strongest
predicting factor for BMD [16], but in this study, no signiﬁcant
correlation was found between these two factors.
Although the signiﬁcant differences in bone density between
subjects with and without metabolic syndrome were reported in
this study, it can be said that metabolic syndrome did not have a
detrimental effect on bone health. Also, the role of protective
mechanisms for bone density in this syndrome is more prominent
than its negative effects due to inﬂammation on bone mineral
density. Other studies also suggest a protective role of metabolic
syndrome on bone density [13].With MS (n = 40) P-value
0.99  0.16 0.29
0.68  1.3 0.07
0.81  0.12 0.37
0.87  0.99 0.23
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syndrome and bone density is a controversial issue, and the
differences between other studies and the present research is
justiﬁed. Further research in this ﬁeld particularly on the
pathophysiologic effects of metabolic syndrome on bone density
seems necessary.
In the present study, as well as other cross sectional studies,
determining a causal relationship between metabolic syndrome
with BMD was difﬁcult. Although, all participants were selected
from one bone densitometry center, but it is necessary to note that
the center was the only densitometry center at the time of the
study. Little research has been done on the subject of this study in
Qazvin province, so this study could be a starting point for further
epidemiological study in this ﬁeld.
5. Conclusion
The present study showed that some parameters of metabolic
syndrome including waist circumference, waist to hip ration, and
serum HDL are signiﬁcantly associated with bone mineral density.
Considering the inconsistent results in this area, more well-
designed studies should be conducted to conﬁrm the relationship
between metabolic syndrome and its component with bone
densitometry.
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